Institute of Biomedical Engineering, College of Engineering and the College of Medicine, National Taiwan University, Taipei, Taiwan.
Korean J Radiol. 2011 May-Jun;12(3):319-26. doi: 10.3348/kjr.2011.12.3.319. Epub 2011 Apr 25.
The purpose of this study is to determine the effects of propranolol on the left ventricular (LV) volume during CT coronary angiography.
The LV volume of 252 normal Chinese subjects (126 subjects with propranolol medication and 126 age- and gender-matched Chinese subjects without medication) was estimated using 64 slices multi-detector CT (MDCT). The heart rate difference was analyzed by the logistic linear regression model with variables that included gender, age, body height, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP) and the dosage of propranolol. The following global LV functional parameters were calculated: the real-end diastolic volume (EDV), the real-end systolic volume (ESV) and the real-ejection fraction (EF).
The female subjects had a greater decrease of heart rate after taking propranolol. The difference of heart rate was negatively correlated with the dosage of propranolol. The real-EDV, the real-ESV and the real-EF ranged from 48.1 to 109 mL/m², 6.1 to 57.1 mL/m² and 41% to 88%, respectively. There was no significant difference in the SBP and DBP between the groups without and with propranolol medication (123 ± 17 and 80 ± 10 mmHg; 120 ± 14 and 80 ± 11 mmHg, respectively). The real-EDV showed no significant difference between these two groups, but the real-ESV and real-EF showed significant differences between these two groups (69.4 ± 9.3 and 70.6 ± 8.9 mL/m²; 23.5 ± 5.7 and 25.6 ± 3.7 mL/m², 66.5 ± 5.1% and 63.5 ± 4.6%, respectively).
The difference of heart rate is significantly influenced by gender and the dosage of propranolol. Propranolol will also increase the ESV, which contributes to a decreased EF, while the SBP, DBP and EDV are not statistically changed.
本研究旨在探讨普萘洛尔对 CT 冠状动脉成像左心室(LV)容积的影响。
采用 64 层多排 CT(MDCT)对 252 例正常中国受试者(126 例服用普萘洛尔药物,126 例年龄和性别匹配的未服用药物的中国受试者)的 LV 容积进行评估。采用逻辑线性回归模型,以性别、年龄、身高、体重、收缩压(SBP)、舒张压(DBP)和普萘洛尔剂量为变量,分析心率差异。计算以下整体 LV 功能参数:真实舒张末期容积(EDV)、真实收缩末期容积(ESV)和真实射血分数(EF)。
女性受试者服用普萘洛尔后心率下降幅度更大。心率差异与普萘洛尔剂量呈负相关。真实 EDV、真实 ESV 和真实 EF 范围分别为 48.1 至 109mL/m²、6.1 至 57.1mL/m² 和 41%至 88%。服用和未服用普萘洛尔药物组之间的 SBP 和 DBP 无显著差异(分别为 123±17 和 80±10mmHg;120±14 和 80±11mmHg)。这两组之间的真实 EDV 无显著差异,但真实 ESV 和真实 EF 存在显著差异(69.4±9.3 和 70.6±8.9mL/m²;23.5±5.7 和 25.6±3.7mL/m²,66.5±5.1%和 63.5±4.6%)。
心率差异受性别和普萘洛尔剂量的显著影响。普萘洛尔还会增加 ESV,从而导致 EF 降低,而 SBP、DBP 和 EDV 无统计学变化。